Literature DB >> 1353539

Cytoskeletal elements regulate the distribution of nerve growth factor receptors in PC12 cells.

P E Spoerri1, F J Roisen.   

Abstract

Nerve growth factor receptor (NGFR)-like immunoreactivity (IR) was studied in PC12 cells treated for 96 hr with NGF (40 ng/ml), using immunogold labeling and electron microscopic morphometric analysis. The cells were exposed to the anti-NGFR antibody 192-IgG, followed by immunoglobulin (IgG) conjugated with colloidal gold. PC12 cells exhibited occasional gold label (positive NGFR-IR) on all surfaces. Cells treated with colcemid (0.05 micrograms/ml) or cytochalasin D (2 micrograms/ml), which limit microtubule (MT) and microfilament (MF) formation, respectively, displayed an increased NGFR-IR in terms of gold labeling. NGFR-IR was also seen on taxol (0.85 micrograms/ml)-exposed cells, an agent that promotes MT assembly. Cells treated simultaneously with cytochalasin D and taxol had a dramatically augmented NGFR-IR on their surfaces, which exceeded levels obtained with either agent alone. Prominent NGFR-IR was localized frequently in coated endocytotic vesicles, in smooth endoplasmic reticulum, and in secondary multivesicular lysosomes, in both treated and untreated cells. The results suggest that a large number of NGFRs (positive NGFR-IR) in PC12 cells are cryptic and not available for ligand binding. Changes in cytoskeletal organization that may affect mobility of integral membrane proteins can modulate the distribution of NGFR-IR on neuronal surfaces.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353539     DOI: 10.1002/jnr.490310312

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  2 in total

Review 1.  Is signal transduction modulated by an interaction between heterotrimeric G-proteins and tubulin?

Authors:  R Ravindra
Journal:  Endocrine       Date:  1997-10       Impact factor: 3.633

2.  Nerve growth factor triggers microfilament assembly and paxillin phosphorylation in human B lymphocytes.

Authors:  I Melamed; C E Turner; K Aktories; D R Kaplan; E W Gelfand
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.